BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5855557)

  • 21. Assessing the value of reflex fluorescence in situ hybridization testing in the diagnosis of bladder cancer when routine urine cytological examination is equivocal.
    Kipp BR; Halling KC; Campion MB; Wendel AJ; Karnes RJ; Zhang J; Sebo TJ
    J Urol; 2008 Apr; 179(4):1296-301; discussion 1301. PubMed ID: 18289582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The localization of tetracycline microfluorescence in tumors of the urinary tract.
    Malis I; Cooper JF
    J Urol; 1968 Feb; 99(2):183-6. PubMed ID: 4170896
    [No Abstract]   [Full Text] [Related]  

  • 23. [ALA fluorescent diagnosis of bladder cancer].
    Al'-Shukri SKh; Danil'chenko DI; Kënig F; Shnorr D
    Urologiia; 2000; (5):48-50. PubMed ID: 11392226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence.
    Kriegmair M; Baumgartner R; Knüchel R; Stepp H; Hofstädter F; Hofstetter A
    J Urol; 1996 Jan; 155(1):105-9; discussion 109-10. PubMed ID: 7490803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinoma in situ of the bladder in workers exposed to xenylamine: diagnosis by ultraviolet light cystoscopy.
    Melick WF; Naryka JJ
    J Urol; 1968 Feb; 99(2):178-82. PubMed ID: 5641074
    [No Abstract]   [Full Text] [Related]  

  • 26. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer.
    Babjuk M; Soukup V; Petrík R; Jirsa M; Dvorácek J
    BJU Int; 2005 Oct; 96(6):798-802. PubMed ID: 16153204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photodinamic effect and fluorescence in the diagnosis and therapy of the cancer of the bladder.
    Fedi B
    Boll Soc Ital Biol Sper; 1977 Jul; 53(14):1138-44. PubMed ID: 603661
    [No Abstract]   [Full Text] [Related]  

  • 28. Fluorescence cystoscopy: is it ready for use in routine clinical practice?
    Spiess PE; Grossman HB
    Curr Opin Urol; 2006 Sep; 16(5):372-6. PubMed ID: 16905985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Rare cases of bladder tumors].
    Kabbaj N; Cherkaoui MM; Dafiri R; Imani F
    J Radiol; 1998 Mar; 79(3):247-52. PubMed ID: 9757245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cytodiagnosis of urine in bladder neoplasms].
    Suzuki S; Shimaya M; Terao E
    Nihon Rinsho; 1976 Nov; 34(11):3340-3. PubMed ID: 1034777
    [No Abstract]   [Full Text] [Related]  

  • 31. Recent developments in fluorescence cystoscopy: do novel agents bring a benefit?
    Schmidbauer J; Marberger M
    Curr Opin Urol; 2007 Sep; 17(5):347-51. PubMed ID: 17762629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience.
    el-Ahmady O; Halim AB; el-Din AG
    Anticancer Res; 1999; 19(4A):2603-8. PubMed ID: 10470202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.
    Schmidbauer J; Witjes F; Schmeller N; Donat R; Susani M; Marberger M;
    J Urol; 2004 Jan; 171(1):135-8. PubMed ID: 14665861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fluorescent cystoscopy in diagnosing and treating superficial cancer of the urinary bladder].
    Gorelov SI
    Urologiia; 2002; (1):25-8. PubMed ID: 11877968
    [No Abstract]   [Full Text] [Related]  

  • 35. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?
    Loidl W; Schmidbauer J; Susani M; Marberger M
    Eur Urol; 2005 Mar; 47(3):323-6. PubMed ID: 15716195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The usefulness of cystoscopy in the staging of cervical cancer.
    Liang CC; Tseng CJ; Soong YK
    Gynecol Oncol; 2000 Feb; 76(2):200-3. PubMed ID: 10637070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence imaging of bladder cancer.
    D'Hallewin MA; Baert L; Vanherzeele H
    Acta Urol Belg; 1994 Dec; 62(4):49-52. PubMed ID: 7793348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incorporating fluorescence cystoscopy for the diagnosis of bladder cancer into clinical practice.
    Karl A; Zaak D; Stief CG
    Nat Clin Pract Urol; 2008 Aug; 5(8):424-5. PubMed ID: 18577979
    [No Abstract]   [Full Text] [Related]  

  • 39. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
    Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
    BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer.
    Witjes JA; Douglass J
    Nat Clin Pract Urol; 2007 Oct; 4(10):542-9. PubMed ID: 17921969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.